Alnylam Pharma (ALNY) Misses Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $224.60 -1.77%
Financial Fact:
Net revenues from research collaborators: 8.71M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Net revenues from research collaborators: 8.71M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q2 EPS of ($0.85), $0.10 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $8.69 million versus the consensus estimate of $12.64 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- XP Inc. (XP) Tops Q2 EPS by 8c
- L3Harris CEO steps down amid conduct review, shares drop
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
